 |
|
|
| |
Estimating the incidence and prevalence of hepatitis C infection in Taiwan using backprojection methods
|
| |
| |
Reported by Jules Levin
APASL 22nd Conference of the Asian Pacific Association for the Study of the Liver
February 16-19, 2012 Taipei, Taiwan
McEwan P1,2 Chen CJ3 Lee MH3 Yang H4 Kim R5 Litalien G6,7 and Yuan Y6
1. Centre for Health Economics, Swansea University, Wales; 2. Health Economics and Outcomes Research Ltd, Monmouth, UK; 3. Academia Sinica, Taipei, Taiwan; 4. China Medical University Hospital, Taichung, Taiwan;
5. Mayo Clinic College of Medicine, Rochester, MN, US; 6. Global Health Economics and Outcomes Research, Bristol-Myers Squibb, Princeton, NJ, US; 7.Yale University School of Medicine, New Haven, CT, US
This study was sponsored by Bristol-Myers Squibb, Princeton,NJ,US
For further information contact: p.c.mcewan@swansea.ac.uk
References
1. Brookmeyer, R. and Gail, M.H. (1986). Minimum size of the Acquired Immunodeficiency Syndrome (AIDS) epidemic in the United States. The Lancet, 2: 1320-22.
2. Becker NG, Watson LF, Carlin JB. (1991) A method of non-parametric back-projection and its application to AIDS data. Stat Med; 10 (10):1527-42
3. Lu et al. (2006). Secular trends and geographic variations of hepatitis B virus and hepatitis C virus-associated hepatocellular carcinoma in Taiwan. Int. J. Cancer: 119, 946-1952
4. Thein HH, Yi Q, Dore GJ and Krahnl MD. (2008) Estimation of Stage-Specific Fibrosis Progression Rates in Chronic Hepatitis C Virus Infection: A Meta- Analysis and
Meta-Regression Hepatology; 48: 418-431
|
| |
|
|
|
|
|
